SCHEMBL9998369

SCHEMBL9998369

CC(=O)OC(OC(C)=O)/C(C)=C/c1ccc(C(C)(C)C)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.45
TRPV1 Q8NER1 7/20 0.40
SMN1; SMN2 Q16637 4/20 0.39
NPC1 O15118 3/20 0.39
MAPT P10636 3/20 0.39
RAB9A P51151 3/20 0.39
MEN1 O00255 3/20 0.39
ALDH1A1 P00352 3/20 0.39
KMT2A Q03164 3/20 0.39
KDM4E B2RXH2 2/20 0.39
LMNA P02545 2/20 0.38
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
POLB P06746 1/20 0.38
HPGD P15428 1/20 0.38
MAPK1 P28482 1/20 0.38
ESRRG P62508 1/20 0.36
HDAC1 Q13547 1/20 0.36
HTT P42858 1/20 0.36
HIF1A Q16665 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9998370 1.00 CYP1A2 (0.45) CYP1A2TRPV1SMN1; SMN2NPC1MAPT
SCHEMBL9998246 0.84 CYP1A2 (0.42) CYP1A2TRPV1SMN1; SMN2NPC1MAPT
SCHEMBL9998247 0.84 CYP1A2 (0.42) CYP1A2TRPV1SMN1; SMN2NPC1MAPT
SCHEMBL9997514 0.83 CYP1A2 (0.41) CYP1A2TRPV1SMN1; SMN2NPC1MAPT
SCHEMBL9997833 0.82 TRPV1 (0.40) TRPV1NPC1RAB9AKMT2ALMNA
SCHEMBL9997834 0.82 TRPV1 (0.40) TRPV1NPC1RAB9AKMT2ALMNA
SCHEMBL9998433 0.81 LMNA (0.41) SMN1; SMN2NPC1MAPTRAB9AALDH1A1
SCHEMBL9998434 0.81 LMNA (0.41) SMN1; SMN2NPC1MAPTRAB9AALDH1A1
SCHEMBL9998462 0.81 CYP1A2 (0.40) CYP1A2TRPV1SMN1; SMN2NPC1MAPT
SCHEMBL9998460 0.81 CYP1A2 (0.40) CYP1A2TRPV1SMN1; SMN2NPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 CYP1A2 19/4885TRPV1 2954/4885SMN1; SMN2 3151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.